Dr. Wray is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2060 Lakeside Centre Way
Knoxville, TN 37922Phone+1 865-218-6222Fax+1 833-671-1059
Education & Training
- Duke University HospitalResidency, Neurology, 1995 - 1998
- Wake Forest University Baptist Medical CenterInternship, Internal Medicine, 1994 - 1995
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1994
Certifications & Licensure
- TN State Medical License 1999 - 2025
- NC State Medical License 1998 - 2002
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study.Barry A Singer, Sibyl Wray, Mark Gudesblatt, Barbara Bumstead, Tjalf Ziemssen
Neurology and Therapy. 2024-08-01 - 2 citationsSafety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Prog...Marco Salvetti, Sibyl Wray, Gereon Nelles, Nicholas Belviso, Achint Kumar
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2024-05-23 - Improvements in no evidence of disease activity with ublituximab vs. teriflunomide in the ULTIMATE phase 3 studies in relapsing multiple sclerosis.Enrique Alvarez, Lawrence Steinman, Edward J Fox, Hans-Peter Hartung, Peiqing Qian
Frontiers in Neurology. 2024-01-01
Press Mentions
- #AANAM – Vumerity Showing Tolerability, Efficacy in Ongoing EVOLVE-MS-1 TrialApril 28th, 2021
- #AANAM – RRMS Patients Switching to Lemtrada Report Greater Satisfaction with Treatment and Improvements in Quality of LifeMay 10th, 2019
- Relapsing Remitting MS Patients Who Received LemtradaMay 6th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: